NCT04082884

Brief Summary

This prospective, open-label pilot/feasibility study of 10 youth with T1D is to evaluate glycemic and metabolic changes taking place with a very low carbohydrate diet.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 9, 2019

Completed
10 months until next milestone

Study Start

First participant enrolled

June 25, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2022

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

June 5, 2023

Completed
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

1.7 years

First QC Date

September 6, 2019

Results QC Date

March 13, 2023

Last Update Submit

February 13, 2024

Conditions

Keywords

very low carbohydrate diet

Outcome Measures

Primary Outcomes (1)

  • Percentage of Time in Target Range of 70-180 mg/dL.

    The target range is 70 mg/dL - 180 mg/dL based on sensor-derived glucose levels. The outcome is reflected as the percentage of time spent in this range during the time frame.

    2 weeks per intervention, up to 7 weeks

Secondary Outcomes (6)

  • Percentage of Time Spent > 180 mg/dL to 250 mg/dl

    2 weeks per intervention, up to 7 weeks

  • Percent Time Spent > 250 mg/dL Based on Sensor-derived Glucose Values

    2 weeks per intervention, up to 7 weeks

  • Percent of Time Spent > = 55 to < 70 mg/dL Based on Sensor-derived Glucose Values

    2 weeks per intervention, up to 7 weeks

  • Percent Time Spent < 55 mg/dL Based on Sensor-derived Glucose Values

    2 weeks per intervention, up to 7 weeks

  • Total Daily Insulin Dose

    2 weeks per intervention, up to 7 weeks

  • +1 more secondary outcomes

Study Arms (1)

Very Low Carbohydrate Diet

EXPERIMENTAL

Participants will follow a high protein very low carbohydrate diet (VLCD) for 2 weeks. This will be 11% of caloric intake from carbohydrates, 54% of calories from protein, and 35% of calories from fat. Immediately following this, participants will follow a high protein very low carbohydrate diet (VLCD) which will be 11% of caloric intake from carbohydrates, 23% of calories from protein, and 66% of calories from fat.

Behavioral: Very Low Carbohydrate Diet

Interventions

A very low carbohydrate diet (VLCD), is defined as limiting carbohydrate intake to 11% of total daily caloric intake.

Very Low Carbohydrate Diet

Eligibility Criteria

Age13 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • BMI 19-30 m2 for individuals at least 18 years old or BMI \< 95 percentile for individuals less than 18 years old
  • Participants 18 years of age must be able to read and provide written consent
  • Participants under 18 years of age must be able to read and provide written assent
  • Participants are managed using an insulin pump or injections
  • Participant has or is willing to wear a CGM for the duration of the study
  • Participant is willing to complete diet logging procedures stated above

You may not qualify if:

  • A1c \< 6.5% or \> 10%
  • Recent history of more than 1 of diabetic ketoacidosis (DKA) in the past 6 months
  • Treatment with glucose-lowering drugs other than insulin
  • Unstable psychiatric disorders, including eating disorders (DSM-V criteria)
  • Weight loss medications within the last 6 months
  • Females who are pregnant, lactating or planning to become pregnant in the next 6 months
  • Another medical condition that precludes participation in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale-New Haven Hospital

New Haven, Connecticut, 06511, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Results Point of Contact

Title
Laura Marie Nally, MD
Organization
Yale School of Medicine

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: Following enrollment, participants will follow a standard carbohydrate diet for 2 weeks. They will then undergo a 1 week transition followed by 2 weeks on a higher protein very low carbohydrate diet that is then followed by 2 weeks on a higher fat very low carbohydrate diet.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2019

First Posted

September 9, 2019

Study Start

June 25, 2020

Primary Completion

February 20, 2022

Study Completion

February 20, 2022

Last Updated

February 15, 2024

Results First Posted

June 5, 2023

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations